Business

Accuray Appoints Franco N. Palomba as VP, Chief Accounting Officer & Controller

SUNNYVALE, Calif., June 15, 2022 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that Franco N. Palomba has joined the company as vice

articleAccuray IncorporatedJune 15, 20224/company/accuray-incorporated/news/accuray-appoints-franco-n-palomba-as-vp-chief-accounting-officer-and-controller
Accuray Appoints Franco N. Palomba as VP, Chief Accounting Officer & Controller

About this update from Accuray Incorporated

[{"type":"text","content":"SUNNYVALE, Calif., June 15, 2022 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that Franco N. Palomba has joined the company as vice president, chief accounting officer & controller. Mr. Palomba will be responsible for the controllership function, including the global accounting organization and associated budgetary and administrative operations, as well as financial and regulatory compliance. He will report to Accuray senior vice president & chief financial officer Ali Pervaiz.\n\n \n \n \n \n \n \n\n \nMr. Palomba is a skilled executive with more than 30 years of accounting and finance expertise, primarily in the radiation therapy industry at Varian Medical Systems, now a part of Siemens Healthineers. Most recently, he served as vice president of finance and controller at Ashvattha Therapeutics where he was responsible for all internal and external resources supporting the successful completion of the company's first multiyear audit, establishment of an internal finance team and closing of a major company funding initiative. Prior to Ashvattha Therapeutics, Mr. Palomba held various leadership positions at Genomic Health, Inc., acquired by Exact Sciences, Varian, and PricewaterhouseCoopers.\n\"Franco is a well-rounded executive with the deep strategic and tactical expertise necessary to help advance our global finance organization and drive the growth of our business. Under his guidance his teams have delivered significant value including streamlining processes, reducing debt and increasing income. We look forward to his leadership at this important time in our organization's evolution,\" said Ali Pervaiz, senior vice president & chief financial officer at Accuray.\n\"The opportunity with Accuray will enable me to re-engage in the radiation therapy industry, an area of particular interest and importance to me. I've always been impressed by the innovation behind the organization's technology and the team's dedication to improving the lives of patients who would benefit from radiation treatments,\" said Franco Palomba, vice president, chief accounting officer & controller at Accuray. \"I'm looking forward to partnering with the global team to help accelerate the company's growth and build shareholder value.\"\nAbout AccurayAccuray is committed to expanding the powerful potential of radiation therapy to impro...

More updates from Accuray Incorporated